课题基金 / 基金详情

Quinolone and multidrug resistance in Staphylococcus aureus

Quinolone and multidrug resistance in Staphylococcus aureus
喹诺酮类药物与金黄色葡萄球菌的多重耐药性
批准号:
8865521
负责人:
David C Hooper
金额:
$39.16万
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-09-01 至 2016-03-31

项目摘要

项目成果

David C Hooper的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Bacterial efflux pumps can cause multidrug resistance when overexpressed, and mutational mechanisms of overexpression have involved an array of global regulators. In Staphylococcus aureus pumps NorA, NorB, and NorC can confer resistance to various quinolone antimicrobials along with chloramphenicol and some dyes. Pump Tet38 confers resistance to tetracyclines, and pump AbcA confers resistance to plactams with hydrophobic side-chains. Two global transcriptional regulators, MgrA and NorG, are known to have direct regulatory roles in the expression of various of these pumps. The work described below has focused on i) defining the regulatory mechanisms that control pump expression (including the complex interactions of various regulators), ii) determination of the role of pump expression in the adaptation of S. aureus to survival in an abscess, its most common cause of infection, iii) determination of the environmental signals that trigger pump expression, and iv) defining the natural substrates of these generally broad-spectrum pumps, for which antimicrobials may be incidental substrates.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Subproject 4 Antimicrobials and Efflux Pumps in Staphylococcus aureus Infection
Antimicrobials and Efflux Pumps in Staphylococcus aureus Infection
Antimicrobials and Efflux Pumps in Staphylococcus aureus Infection
Subproject 4: Role of Pumps in Resistance, Physiology, and Infection
海外基金